(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SHIRE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SHIRE

ST13

US500000087102856

Class

5, 44

Filing

87102856

Registration

6200622

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

59

Latest update

11/18/2025

Trademark type

Word

Nice classes

5, 44

Filing date

07/13/2016

Registration date

11/17/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/17/2020

Last transaction

11/18/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

1999-00-00

First use in commerce

1999-00-00

Drawing code

4

Owner type

25

Owner location

GLATTPARK-OPFIKON, CH

Examiner

KENEALY,NATALIE LANGFORD

Law office

L40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

TAKEDA PHARMACEUTICALS INTERNATIONAL AG
SHIRE PHARMACEUTICALS IRELAND LIMITED
Shire Pharmaceutical Holdings Ireland Limited
Shire Pharmaceutical Holdings Ireland Limited

Representatives

Karl M. Zielaznicki Troutman Pepper Hamilton Sanders LLP

Technical classification

Nice Classes

Class 5Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

A full line of pharmaceuticalspharmaceuticals for the treatment of angioedemacancereating disordersenzyme deficienciesgastrointestinal disordersgenetic diseaseshematologic disordershormonal disordersimmunologic disordersneurological disordersophthalmic disorders and protein deficiencies; drug delivery apparatuspre-filled medical fluid injectors for the delivery of pharmaceuticals

Class 44

Providing medical information and health care information; Providing medical information and health care information in connection with patient support programs; Providing medical information and health care information to improve understanding about pharmaceuticals and medical treatments by health care providerspatientspatients' families and the general public; Health care services

Publications

History of USPTO decisions and trademark events.

59 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

11/17/2025

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

02/23/2022

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

11/25/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

11/17/2020

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

10/14/2020

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

10/13/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/24/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/23/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/23/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/20/2020

GNRT

NON-FINAL ACTION E-MAILED

07/20/2020

CNRT

SU - NON-FINAL ACTION - WRITTEN

07/20/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/14/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/14/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/14/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/14/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/14/2020

SUPC

STATEMENT OF USE PROCESSING COMPLETE

06/26/2020

IUAF

USE AMENDMENT FILED

06/25/2020

EISU

TEAS STATEMENT OF USE RECEIVED

06/25/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/18/2020

EX5G

SOU EXTENSION 5 GRANTED

01/17/2020

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

01/17/2020

EXT5

SOU EXTENSION 5 FILED

01/15/2020

EEXT

SOU TEAS EXTENSION RECEIVED

01/15/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/06/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/06/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/06/2019

EX4G

SOU EXTENSION 4 GRANTED

07/04/2019

EXT4

SOU EXTENSION 4 FILED

07/04/2019

EEXT

SOU TEAS EXTENSION RECEIVED

07/04/2019

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

02/04/2019

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

02/04/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/08/2019

EX3G

SOU EXTENSION 3 GRANTED

01/04/2019

EXT3

SOU EXTENSION 3 FILED

01/04/2019

EEXT

SOU TEAS EXTENSION RECEIVED

01/04/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/07/2018

EX2G

SOU EXTENSION 2 GRANTED

07/05/2018

EXT2

SOU EXTENSION 2 FILED

07/05/2018

EEXT

SOU TEAS EXTENSION RECEIVED

07/05/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/09/2018

EX1G

SOU EXTENSION 1 GRANTED

01/07/2018

EXT1

SOU EXTENSION 1 FILED

01/07/2018

EEXT

SOU TEAS EXTENSION RECEIVED

01/07/2018

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

07/18/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/23/2017

PUBO

PUBLISHED FOR OPPOSITION

05/23/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/03/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/10/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/07/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/07/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/07/2017

GPRN

NOTIFICATION OF PRIORITY ACTION E-MAILED

10/28/2016

GPRA

PRIORITY ACTION E-MAILED

10/28/2016

CPRA

PRIORITY ACTION WRITTEN

10/28/2016

DOCK

ASSIGNED TO EXAMINER

10/24/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/19/2016

NWAP

NEW APPLICATION ENTERED

07/16/2016

Continuous trademark protection

Get notified about every new filing that threatens SHIRE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.